All Sauce from Weekly Sauce:

One of the two most common drugs used to treat age-related macular degeneration (AMD) appears better than the other, a new, small study suggests. Among 106 patients with “wet” age-related macular degeneration, 50% of those treated with aflibercept (Eylea) could be weaned off the drug after one year, compared with only 17% of those treated…  read on >  read on >

WEDNESDAY, Dec. 7, 2022 (HealthDay News) – How singers use their voices, including the genre of music they perform, has an impact on vocal injury, new research finds. Dr. Lesley Childs, medical director of the Voice Center at University of Texas Southwestern in Dallas, led a two-part study of more than 1,000 patient records. The…  read on >  read on >

A facial scar may make a person self-conscious, but it doesn’t change another person’s first impressions of their attractiveness or confidence, a new survey shows. The results found that a single, well-healed facial scar may even increase perceived friendliness, according to the researchers, who had predicted different results and said the findings might be “surprising…  read on >  read on >

WEDNESDAY, Dec. 7, 2022 (HealthDay News) – The U.S. Food and Drug Administration’s foods program is in “constant turmoil” and needs stronger leadership, a panel said Thursday. The Reagan-Udall Foundation, a group with close ties to the FDA, released a 51-page report Tuesday noting the need for a clear mission in the program and more…  read on >  read on >

Depression may be a disorder of the brain, but new research adds to evidence that it also involves the gut. While depression is complex, recent research has been pointing to a role for bacteria that dwell in the gut — suggesting that certain bacterial strains might feed depression symptoms, while others might be protective. In…  read on >  read on >